Brevan Howard Capital Management’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77.2K Sell
17,466
-54,534
-76% -$323K ﹤0.01% 2058
2025
Q4
$386K Buy
72,000
+10,880
+18% +$86.5K ﹤0.01% 1235
2025
Q3
$588K Buy
+61,120
New +$564K ﹤0.01% 1199
2024
Q2
Sell
-24,359
Closed -$101K 1062
2024
Q1
$101K Buy
+24,359
New +$75.1K ﹤0.01% 893

Other funds holding ASPI

Brevan Howard Capital Management's ASPI Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its ASP Isotopes (ASPI) stake by 76% in Q1 2026, selling an estimated $323K and leaving 17,466 shares worth $77.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2058.

Brevan Howard Capital Management first reported a position in ASPI in Q1 2024 and has held it in 4 quarters since. The position peaked at $588K in Q3 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.

  • Brevan Howard Capital Management held 17,466 shares of ASP Isotopes worth $77.2K as of Q1 2026.
  • Brevan Howard Capital Management sold 54,534 ASP Isotopes shares in Q1 2026, an estimated $323K.
  • ASP Isotopes made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #2058 holding.
  • Brevan Howard Capital Management first reported a position in ASP Isotopes in Q1 2024 and has held it in 4 quarters since.
  • Brevan Howard Capital Management's ASP Isotopes position peaked at $588K in Q3 2025.
  • 177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.